Circulating Cell-Free DNA as a Non-Invasive Marker of Pediatric Heart Transplant Rejection and Immunosuppressive Treatment

Journal of Heart and Lung Transplantation - Netherlands
doi 10.1016/j.healun.2016.01.205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Circulating Cell-Free DNA and Its Integrity as a Prognostic Marker for Breast Cancer

SpringerPlus
Multidisciplinary
2015English

Circulating Cell Free DNA as the Diagnostic Marker for Colorectal Cancer: A Systematic Review and Meta-Analysis

Oncotarget
Oncology
2018English

Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2016English

Circulating Cell-Free DNA

2019English

Cell-Free Fetal DNA and Non-Invasive Prenatal Diagnosis

British Journal of General Practice
MedicineFamily Practice
2009English

Genome-Wide Mapping of 5-Hydroxymethylcytosines in Circulating Cell-Free DNA as a Non-Invasive Approach for Early Detection of Hepatocellular Carcinoma

Gut
Gastroenterology
2019English

Plasma Cd5l and Non-Invasive Diagnosis of Acute Heart Rejection

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2020English

N-Terminal Pro-Brain Natriuretic Peptide as a Potential Non-Invasive Marker of Cardiac Transplantation Rejection

Annals of Clinical Biochemistry
MedicineClinical Biochemistry
2007English

Circulating Cell-Free DNA as a Prognostic and Molecular Marker for Patients With Brain Tumors Under Perillyl Alcohol-Based Therapy

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy